Publicacions en què col·labora amb Jose Rivera Pozo (9)

2016

  1. Hsp70 protects from stroke in atrial fibrillation patients by preventing thrombosis without increased bleeding risk

    Cardiovascular Research, Vol. 110, Núm. 3, pp. 309-318

2009

  1. The influence of riboflavin photochemistry on plasma coagulation factors

    Transfusion and Apheresis Science, Vol. 41, Núm. 3, pp. 199-204

2008

  1. JAK2 V617F, hemostatic polymorphisms, and clinical features as risk factors for arterial thrombotic events in essential thrombocythemia

    Annals of Hematology

  2. TUBB1 Q43P polymorphism does not protect against acute coronary syndrome and premature myocardial infarction

    Thrombosis and Haemostasis

2007

  1. The association of the β1-tubulin Q43P polymorphism with intracerebral hemorrhage in men

    Haematologica, Vol. 92, Núm. 4, pp. 513-518

2003

  1. Role of factor XIII Val34Leu polymorphism in patients <45 years of age with acute myocardial infarction

    American Journal of Cardiology, Vol. 91, Núm. 10, pp. 1242-1245

  2. The -1C>T mutation in the annexin A5 gene does not affect plasma levels of annexin A5 [2] (multiple letters)

    Blood

2002

  1. A common polymorphism in the annexin V Kozak sequence (-1C>T) increases translation efficiency and plasma levels of annexin V, and decreases the risk of myocardial infarction in young patients

    Blood, Vol. 100, Núm. 6, pp. 2081-2086

  2. Effect of factor XIII VAL34LEU polymorphism on thrombolytic therapy in premature myocardial infarction

    Thrombosis and Haemostasis